A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population
British Committee for Standards in Haematology, Milkins C, Berryman J, Cantwell C, et al. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med 2013;23:3–35.British Committee for Standards in HaematologyMilkinsCBerrymanJCantwellCGuidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology.Transfus Med2013;23:3–35.10.1111/j.1365-3148.2012.01199.x23216974Search in Google Scholar
Boral LI, Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures. Transfusion 1977;17:163–8.BoralLIHenryJB.The type and screen: a safe alternative and supplement in selected surgical procedures.Transfusion1977;17:163–8.10.1046/j.1537-2995.1977.17277151923.x403642Search in Google Scholar
Technical manual, 20th ed. Bethesda, MD: AABB, 2020.Technical manual, 20th ed. Bethesda, MD: AABB,2020.Search in Google Scholar
Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the major crossmatch in urgent or massive transfusion. Transfusion 1978;18:137–41.ObermanHABarnesBAFriedmanBA.The risk of abbreviating the major crossmatch in urgent or massive transfusion.Transfusion1978;18:137–41.10.1046/j.1537-2995.1978.18278160574.x417431Search in Google Scholar
Cordle DG, Strauss RG, Snyder EL, Floss AM. Safety and cost-containment data that advocate abbreviated pretransfusion testing. Am J Clin Pathol 1990;94:428–31.CordleDGStraussRGSnyderELFlossAM.Safety and cost-containment data that advocate abbreviated pretransfusion testing.Am J Clin Pathol1990;94:428–31.10.1093/ajcp/94.4.4282220670Search in Google Scholar
Heddle NM, O’Hoski P, Singer J, McBride JA, Ali MA, Kelton JG. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol 1992;81:579–84.HeddleNMO’HoskiPSingerJMcBrideJAAliMAKeltonJG.A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.Br J Haematol1992;81:579–84.10.1111/j.1365-2141.1992.tb02995.x1390245Search in Google Scholar
The Drug and Cosmetics Act, 1940, and the Drug and Cosmetics Rules, 1945, as amended up to 30th June, 2005. Schedule F. Part XIIB. Central Drugs Standard Control Organization. Director General of Health Services. Ministry of Health and Family Welfare. Government of India; 268–288. Available from http://www.cdsco.nic.in/writereaddata/drugs&cosmeticact.pdf. Accessed 22 January 2022.The Drug and Cosmetics Act, 1940, and the Drug and Cosmetics Rules, 1945, as amended up to 30th June, 2005.Schedule F. Part XIIB. Central Drugs Standard Control Organization. Director General of Health Services. Ministry of Health and Family Welfare. Government of India; 268–288. Available fromhttp://www.cdsco.nic.in/writereaddata/drugs&cosmeticact.pdf.Accessed 22 January 2022.Search in Google Scholar
National Standards for Blood Centres and Blood Transfusion Services, 2nd ed., Ministry of Health & Family Welfare, Government of India, 2022.National Standards for Blood Centres and Blood Transfusion Services, 2nd ed., Ministry of Health & Family Welfare, Government of India,2022.Search in Google Scholar
Roberts N, James S, Delaney M, Fitzmaurice C. The global need and availability of blood products: a modelling study. Lancet Haematol 2019;6:e606–15.RobertsNJamesSDelaneyMFitzmauriceC.The global need and availability of blood products: a modelling study. Lancet Haematol2019;6:e606–15.10.1016/S2352-3026(19)30200-531631023Search in Google Scholar
Tiwari AK, Aggarwal G, Dara RC, Arora D, Gupta GK, Raina V. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients. Asian J Transfus Sci 2017;11:40–4.TiwariAKAggarwalGDaraRCAroraDGuptaGKRainaV.First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.Asian J Transfus Sci2017;11:40–4.10.4103/0973-6247.200774534527928316439Search in Google Scholar
Pathak S, Chandrashekhar M, Wankhede GR. Type and screen policy in the blood bank: is AHG cross-match still required? A study at a multispecialty corporate hospital in India. Asian J Transfus Sci 2011;5:153–6.PathakSChandrashekharMWankhedeGR.Type and screen policy in the blood bank: is AHG cross-match still required? A study at a multispecialty corporate hospital in India.Asian J Transfus Sci2011;5:153–6.10.4103/0973-6247.83242315924621897595Search in Google Scholar
Agrawal A. Type and screen policy: is there any compromise on blood safety? Transfus Apher Sci 2014;50:271–3.AgrawalA.Type and screen policy: is there any compromise on blood safety?Transfus Apher Sci2014;50:271–3.10.1016/j.transci.2014.01.00324472664Search in Google Scholar
Chaudhary R, Agarwal N. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting. Asian J Transfus Sci 2011;5:157–9.ChaudharyRAgarwalN.Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting.Asian J Transfus Sci2011;5:157–9.10.4103/0973-6247.83243315924721897596Search in Google Scholar
Boral LI, Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures. Transfusion 1977;17:163–8.BoralLIHenryJB.The type and screen: a safe alternative and supplement in selected surgical procedures.Transfusion1977;17:163–8.10.1046/j.1537-2995.1977.17277151923.x403642Search in Google Scholar
Bruggeman CW, Nagelkerke SQ, Lau W, et al. Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products. Blood Adv 2020;4:3416–26.BruggemanCWNagelkerkeSQLauWTreatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products.Blood Adv2020;4:3416–26.10.1182/bloodadvances.2020002253739113432722782Search in Google Scholar
Bachofner A, Rüfli T, Holbro A, et al. The remarkable journey of a low-frequency alloantibody. Transfus Med Hemother 2019;46:384–5.BachofnerARüfliTHolbroAThe remarkable journey of a low-frequency alloantibody.Transfus Med Hemother2019;46:384–5.10.1159/000490503687658431832065Search in Google Scholar
Mintz PD, Haines AL, Sullivan MF. Incompatible crossmatch following nonreactive antibody detection test. Transfusion 1982;22:107–10.MintzPDHainesALSullivanMF.Incompatible crossmatch following nonreactive antibody detection test.Transfusion1982;22:107–10.10.1046/j.1537-2995.1982.22282177114.x7071913Search in Google Scholar
Garratty G. Abbreviated pretransfusion testing. Transfusion 1986;26:217–9.GarrattyG.Abbreviated pretransfusion testing.Transfusion1986;26:217–9.10.1046/j.1537-2995.1986.26386209371.x3085295Search in Google Scholar
Oberman HA, Barnes BA, Steiner EA. Role of the crossmatch in testing for serologic incompatibility. Transfusion 1982;22: 12–6.ObermanHABarnesBASteinerEA.Role of the crossmatch in testing for serologic incompatibility. Transfusion1982;22: 12–6.10.1046/j.1537-2995.1982.22182154207.x6801826Search in Google Scholar
Pandey P, Setya D, Srivastava R, Singh MK. A prospective, observational study for optimization of antibody screening in pretransfusion compatibility testing. Immunohematology 2020;36:19–28.PandeyPSetyaDSrivastavaRSinghMK.A prospective, observational study for optimization of antibody screening in pretransfusion compatibility testing.Immunohematology2020;36:19–28.10.21307/immunohematology-2020-038Search in Google Scholar
Datta SS, Mukherjee S, Talukder B, Bhattacharya P, Mukherjee K. Frequency of red cell alloimmunization and autoimmunization in thalassemia patients: a report from Eastern India. Adv Hematol 2015;2015:610931.DattaSSMukherjeeSTalukderBBhattacharyaPMukherjeeK.Frequency of red cell alloimmunization and autoimmunization in thalassemia patients: a report from Eastern India.Adv Hematol2015;2015:610931.10.1155/2015/610931457573226425124Search in Google Scholar
Shastry S, Chenna D, Basavarajegowda A, Das S, Chaudhary RK. Red blood cell alloimmunization among recipients of blood transfusion in India: a systematic review and meta-analysis. Vox Sang 2022;117:1057–69. doi: 10.1111/vox.13296.ShastrySChennaDBasavarajegowdaADasSChaudharyRK.Red blood cell alloimmunization among recipients of blood transfusion in India: a systematic review and meta-analysis.Vox Sang2022;117:1057–69. doi:10.1111/vox.13296.35608911Open DOISearch in Google Scholar
Basu D, Datta SS, Montemayor C, Bhattacharya P, Mukharjee K, Flegel WA. ABO, Rhesus, and Kell antigens, alleles, and haplotypes in West Bengal, India. Transfus Med Hemother 2018;45:62–6.BasuDDattaSSMontemayorCBhattacharyaPMukharjeeKFlegelWA.ABO, Rhesus, and Kell antigens, alleles, and haplotypes in West Bengal, India.Transfus Med Hemother2018;45:62–6.10.1159/000475507583628329593462Search in Google Scholar
Perkins RP. The significance of the anti-Lewis antibodies in pregnancy. Am J Obstet Gynecol 1970;107:28–32.PerkinsRP.The significance of the anti-Lewis antibodies in pregnancy.Am J Obstet Gynecol1970;107:28–32.10.1016/S0002-9378(16)33886-8Search in Google Scholar
Das S, Shastry S, Rai L, Baliga PB. Frequency and clinical significance of red cell antibodies in pregnancy: a prospective study from India. Indian J Pathol Microbiol 2020;63:241–6.DasSShastrySRaiLBaligaPB.Frequency and clinical significance of red cell antibodies in pregnancy: a prospective study from India.Indian J Pathol Microbiol2020;63:241–6.10.4103/IJPM.IJPM_737_1932317523Search in Google Scholar
Aggarwal G, Tiwari AK, Arora D, et al. Advantages of type and screen policy: perspective from a developing country! Asian J Transfus Sci 2018;12:42–5.AggarwalGTiwariAKAroraDAdvantages of type and screen policy: perspective from a developing country!Asian J Transfus Sci2018;12:42–5.10.4103/ajts.AJTS_31_17585069629563674Search in Google Scholar